Sign In
Buy ACST
$3.37
+0 (+0%)
At Close: Jan 24, 2025
20 Healthcare Stocks Moving In Monday's Pre-Market Session
12:32pm, Monday, 16'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo Corporation (NASDAQ: MASI ) Down In The Dum
Acasti Pharma Awarded Notice of Allowance for Additional Composition of Matter and Method of Use Patents in the United States and Mexico
12:00pm, Wednesday, 11'th Mar 2020
LAVAL, Québec, March 11, 2020 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, devel
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Enzo Bi
Amarin Stock Looks Like a Heart-Healthy Buy on the Dip
11:50am, Friday, 06'th Mar 2020
The weak performance of Amarin (NASDAQ:AMRN) has been a head scratcher. Back in December, the company announced a major approval from the U.S. Food and Drug Administration. There was also a strong fou
3 Big Stock Charts for Tuesday: Amarin, Campbell Soup, and Church & Dwight
12:22pm, Tuesday, 03'rd Mar 2020
Tuesday's big stock charts feature three big winners in Monday's big rally — all of which have hopes for further upside ahead.
Acasti Receives NASDAQ Notification Regarding Minimum Bid Requirements
10:00pm, Friday, 28'th Feb 2020
LAVAL, Québec, Feb. 28, 2020 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, develo
Look Anywhere but Acasti Pharma Stock for Opportunity
07:48pm, Friday, 28'th Feb 2020
With shares down more than 80%, is there opportunity with Acasti Pharma (NASDAQ:ACST) stock? Don't bet on it! Shares have been hammered since January due to poor Phase 3 results for its prospective hy
Confounding Decline Creates an Opportunity in Amarin Stock
03:07pm, Friday, 28'th Feb 2020
Amarin stock has declined by nearly a quarter so far in 2020 on little news. That lower valuation makes AMRN intriguing.
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
12:28pm, Friday, 28'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on Feb. 27)
Global Cord Blood Corp (...
Acasti Receives NASDAQ Notification Regarding Minimum Bid Requirements
12:00am, Friday, 28'th Feb 2020First-Mover Advantage Will Benefit Amarin Stock More Than You Think
12:10pm, Monday, 24'th Feb 2020
There’s no reason Amarin stock won’t become a big success with Vascepa, especially with access to millions of patients.
